FDA Modernization Act: implications for oncology.

Abstract

The Food and Drug Administration (FDA) Modernization Act, signed into law on November 21, 1997, represents a sweeping review of existing standards for the approval, labeling, and promotion of prescription medicines. Certain sections of the act will influence access that oncologists and their patients have to new treatments and to information about those… (More)

Topics

  • Presentations referencing similar topics